|
1
|
Irani SR, Pettingill P, Kleopa KA, Schiza
N, Waters P, Mazia C, Zuliani L, Watanabe O, Lang B, Buckley C and
Vincent A: Morvan syndrome: Clinical and serological observations
in 29 cases. Ann Neurol. 72:241–255. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Morvan A: De la chorèe fibrillaire.
Gazzette Hebdomadaire de Mèdecine et de Chirurgie. 27:173–200.
1890.
|
|
3
|
Robain O and Attal C: Morvan's analgesic
panaris in a 7-year-old child. Arch Fr Pediatr. 31:405–410.
1974.(In French). PubMed/NCBI
|
|
4
|
Murri L, Bonuccelli U, Iudice A and
Simonetti C: Sleep disturbances in a case of Morvan's chorea
(author's transl). Riv Patol Nerv Ment. 97:350–356. 1976.(In
Italian). PubMed/NCBI
|
|
5
|
Lee EK, Maselli RA, Ellis WG and Agius MA:
Morvan's fibrillary chorea: A paraneoplastic manifestation of
thymoma. J Neurol Neurosurg Psychiatry. 65:857–862. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jaben EA and Winters JL: Plasma exchange
as a therapeutic option in patients with neurologic symptoms due to
antibodies to voltage-gated potassium channels: A report of five
cases and review of the literature. J Clin Apher. 27:267–273. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Otani S, Kawamura M, Sasaki H, Nakazawa S,
Ohara H, Shimada T, Kamitani T, Asato Y, Suzuki M and Sekizuka E:
Case report; A case of Morvan syndrome: a paraneoplastic
manifestation of angioimmunoblastic T-cell lymphoma. Nihon Naika
Gakkai Zasshi. 101:3519–3521. 2012.(In Japanese). View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Loukaides P, Schiza N, Pettingill P,
Palazis L, Vounou E, Vincent A and Kleopa KA: Morvan's syndrome
associated with antibodies to multiple components of the
voltage-gated potassium channel complex. J Neurol Sci. 312:52–56.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Abou-Zeid E, Boursoulian LJ, Metzer WS and
Gundogdu B: Morvan syndrome: A case report and review of the
literature. J Clin Neuromuscul Dis. 13:214–227. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ong E, Viaccoz A, Ducray F, Pérol M,
Cavillon G, Rogemond V, Honnorat J and Petiot P: Dramatic
improvement after rituximab in a patient with paraneoplastic
treatment-refractory Morvan syndrome associated with anti-CASPR2
antibodies. Eur J Neurol. 20:e96–e97. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lukas RV, Rezania K, Malec M and Salgia R:
Teaching Video NeuroImages: Myokymia and nerve hyperexcitability as
components of Morvan syndrome due to malignant thymoma. Neurology.
80:e552013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sharma S and Sharma P: Morvan syndrome:
After scrotal sac drainage and chemical instillation in hydrocele.
Neurol India. 61:300–302. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li Y, Ren H, Ren M, Cui F, Yang F, Chen Z,
Cui L and Huang X: Morvan syndrome plus thyroid dysfunction: A case
with chronic mercury exposure. Neurol India. 62:218–219. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Abgrall G, Demeret S, Rohaut B,
Leu-Semenescu S and Arnulf I: Status dissociatus and disturbed
dreaming in a patient with Morvan syndrome plus myasthenia gravis.
Sleep Med. 16:894–896. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Benedetti L, Franciotta D, Zoccarato M,
Beronio A, Godani M, Schirinzi E, Siciliano G, Ciarmiello A and Del
Sette M: Post-therapy normalization of brain FDG-PET in Morvan's
syndrome. J Neurol Sci. 353:175–176. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ehler E and Meleková A: Neuromyotonia with
polyneuropathy, prominent psychoorganic syndrome, insomnia, and
suicidal behavior without antibodies: A case report. J Med Case
Rep. 9:1012015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Baas G Horta: Intravenous immunoglobulin
therapy in Morvan syndrome secondary to recurrent thymic carcinoma.
Medwave. 15:e63232015.(In Spanish). View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Baiardi S, Provini F, Avoni P, Pasquinelli
M and Liguori R: Immunotherapy of oneiric stupor in Morvan
syndrome: Efficacy documented by actigraphy. Neurology.
84:2457–2459. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Laurencin C, André-Obadia N, Camdessanché
JP, Mauguière F, Ong E, Vukusic S, Peter-Derex L, Meyronet D,
Bouhour F, Vial C, et al: Peripheral small fiber dysfunction and
neuropathic pain in patients with Morvan syndrome. Neurology.
85:2076–2078. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lotan I, Djaldetti R, Hellman MA and
Benninger F: Atypical case of Morvan's syndrome. J Clin Neurosci.
25:132–134. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Macaron G, El Rassy E and Koussa S: Morvan
syndrome secondary to thymic carcinoma in a patient with systemic
lupus erythematosus. Case Rep Neurol Med.
2016:91424862016.PubMed/NCBI
|
|
22
|
Mather H: A complicated case of metastatic
thymoma. BMJ Support Palliat Care. 6:116–118. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang L, Lu Q, Guan HZ, Mei JH, Ren HT,
Liu MS, Peng B and Cui LY: A Chinese female Morvan patient with
LGI1 and CASPR2 antibodies: A case report. BMC Neurol. 16:372016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Maskery M, Chhetri SK, Dayanandan R, Gall
C and Emsley HC: Morvan syndrome: A case report with patient
narrative and video. Neurohospitalist. 6:32–35. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Detterbeck FC, Nicholson AG, Kondo K, Van
Schil P and Moran C: The Masaoka-Koga stage classification for
thymic malignancies: Clarification and definition of terms. J
Thorac Oncol. 6(7 Suppl 3): S1710–S17168. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Travis WD, Brambilla E, Müller-Hermelink
HK and Harris CC: World Health Organization Classification of
Tumours. Pathology and Genetics of Tumours of the Lung, Pleura,
Thymus and Heart (3rd). IARC Press. (Lyon). 2004.
|
|
27
|
Ware JE Jr and Sherbourne CD: The MOS
36-item short-form health survey (SF-36). I. Conceptual framework
and item selection. Med Care. 30:473–483. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Eng TY, Fuller CD, Jagirdar J, Bains Y and
Thomas CR Jr: Thymic carcinoma State of the art review. Int J
Radiat Oncol Biol Phys. 59:654–664. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kegel L, Aunin E, Meijer D and Bermingham
JR: LGI proteins in the nervous system. ASN Neuro. 5:167–181. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Irani SR, Alexander S, Waters P, Kleopa
KA, Pettingill P, Zuliani L, Peles E, Buckley C, Lang B and Vincent
A: Antibodies to Kv1 potassium channel-complex proteins
leucine-rich, glioma inactivated 1 protein and contactin-associated
protein-2 in limbic encephalitis, Morvan's syndrome and acquired
neuromyotonia. Brain. 133:2734–2748. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Arroyo EJ, Xu YT, Zhou L, Messing A, Peles
E, Chiu SY and Scherer SS: Myelinating Schwann cells determine the
internodal localization of Kv1.1, Kv1.2, Kvbeta2, and Caspr. J
Neurocytol. 28:333–347. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Poliak S, Gollan L, Martinez R, Custer A,
Einheber S, Salzer JL, Trimmer JS, Shrager P and Peles E: Caspr2, a
new member of the neurexin superfamily, is localized at the
juxtaparanodes of myelinated axons and associates with K+ channels.
Neuron. 24:1037–1047. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Plantone D, Renna R and Koudriavtseva T:
Neurological diseases associated with autoantibodies targeting the
voltage-gated potassium channel complex: Immunobiology and clinical
characteristics. Neuroimmunol Neuroinflamm. 3:69–78. 2016.
|
|
34
|
Bernard C, Frih H, Pasquet F, Kerever S,
Jamilloux Y, Tronc F, Guibert B, Isaac S, Devouassoux M,
Chalabreysse L, et al: Thymoma associated with autoimmune diseases:
85 cases and literature review. Autoimmun Rev. 15:82–92. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cottrell DA, Blackmore KJ, Fawcett PRW,
Birchall D, Vincent A, Barnard S and Walls TJ: Sub-acute
presentation of Morvan's syndrome after thymectomy. J Neurol
Neurosurg Psychiatry. 75:1504–510. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lai M, Huijbers MG, Lancaster E, Graus F,
Bataller L, Balice-Gordon R, Cowell JK and Dalmau J: Investigation
of LGI1 as the antigen in limbic encephalitis previously attributed
to potassium channels: A case series. Lancet Neurol. 9:776–785.
2010. View Article : Google Scholar : PubMed/NCBI
|
